0

Bevirimat

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP174022425
CAS174022-42-5
Structure
MDL NumberMFCD00954243
Molecular Weight584.83
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 Infection

David E Martin, Karl Salzwedel, Graham P Allaway

Antivir Chem Chemother. 2008;19(3):107-13.

PMID: 19024627

1

Improved Bevirimat Resistance Prediction by Combination of Structural and Sequence-Based Classifiers

J Nikolaj Dybowski, Mona Riemenschneider, Sascha Hauke, Martin Pyka, Jens Verheyen, Daniel Hoffmann, Dominik Heider

BioData Min. 2011 Nov 14;4:26.

PMID: 22082002

1

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice

Cheryl A Stoddart, Pheroze Joshi, Barbara Sloan, Jennifer C Bare, Philip C Smith, Graham P Allaway, Carl T Wild, David E Martin

PLoS One. 2007 Nov 28;2(11):e1251.

PMID: 18043758

1

Resistance to Second-Generation HIV-1 Maturation Inhibitors

Emiko Urano, Uddhav Timilsina, Justin A Kaplan, Sherimay Ablan, Dibya Ghimire, Phuong Pham, Nishani Kuruppu, Rebecca Mandt, Stewart R Durell, Theodore J Nitz, David E Martin, Carl T Wild, Ritu Gaur, Eric O Freed

J Virol. 2019 Mar 5;93(6):e02017-18.

PMID: 30567982

1

The Prototype HIV-1 Maturation Inhibitor, Bevirimat, Binds to the CA-SP1 Cleavage Site in Immature Gag Particles

Albert T Nguyen, Christa L Feasley, Ken W Jackson, Theodore J Nitz, Karl Salzwedel, Gillian M Air, Michael Sakalian

Retrovirology. 2011 Dec 7;8:101.

PMID: 22151792

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode